A

Adial Pharmaceuticals
D

ADIL

1.01000
USD
0.00
(0.00%)
Market Closed
Volume
5,807
EPS
-4
Div Yield
-
P/E
-0
Market Cap
6,469,839
News

Title: Adial Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.